Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Gastrulation brain homeobox 2 (GBX2)** is a transcription factor encoded by the GBX2 gene, belonging to the homeobox protein family[1][4][6]. It is a sequence-specific DNA-binding protein crucial for the development and regionalization of the central nervous system, particularly of the midbrain and hindbrain during embryogenesis[1][2][4]. GBX2 regulates the segmentation of the hindbrain into rhombomeres 1-3 and influences the expression of other developmental genes such as FGF8 and Otx2[1][4]. Its activity is essential for neural crest cell migration, nervous system patterning, and aspects of cardiovascular development[4]. Dysregulation or mutation of GBX2 is associated with congenital anomalies (including Opitz-Gbbb syndrome and craniofacial/cardiovascular defects) and has been linked to certain cancers[1][2]. There are currently no drugs known to directly target GBX2, nor is it considered a therapeutic target; its essential role in fundamental developmental processes makes it primarily of interest for developmental biology and genetics, not for drug targeting[1][6].
Not applicable (no known or reported drugs directly targeting GBX2 as a therapeutic mechanism)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrulation brain homeobox 2 (GBX2).